George D. Yancopoulos

George D. Yancopoulos, M.D., Ph.D., co-founder, president, and chief scientific officer of Regeneron, is a prominent figure in biotechnology and medical innovation. He co-invented Regeneron's foundational technologies for drug discovery and led breakthrough treatments for diseases like cancer, heart disease, and rheumatoid arthritis.

• Education
  • Valedictorian, Bronx High School of Science
  • Columbia University (M.D. and Ph.D. in biochemistry and molecular biophysics)
• Research Interests
  • Biotechnology innovation
  • Genetics and drug discovery
  • Immunology and molecular medicine
• Scientific Leadership
  • Over 300 publications and 100 patents
  • Regeneron Genetics Center (500,000+ exomes sequenced)
  • Recognized as one of the most cited scientists in the 1990s
• Awards
  • Elected to National Academy of Sciences (2004)
  • Biotech Hall of Fame (2014)
  • Ernst & Young Entrepreneur of the Year (2016)
• STEM Advocacy
  • Revived the Regeneron Science Talent Search (formerly sponsored by Westinghouse and Intel)
  • Passionate about inspiring young scientists through internships and STEM programs